MED13L-GTF2IRD1 Fusion FISH Probe
The MED13L-GTF2IRD1 Fusion FISH Probe is used to confirm a fusion of the MED13L and GTF2IRD1 genes. The fusion of the MED13L and GTF2IRD1 genes has been associated with Breast Invasive Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| MED13L-GTF2IRD1-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| MED13L-GTF2IRD1-20-RERE | 20 (40 μL) | 200 μL |
|
|
| MED13L-GTF2IRD1-20-REOR | 20 (40 μL) | 200 μL |
|
|
| MED13L-GTF2IRD1-20-REGO | 20 (40 μL) | 200 μL |
|
|
| MED13L-GTF2IRD1-20-REGR | 20 (40 μL) | 200 μL |
|
|
| MED13L-GTF2IRD1-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| MED13L-GTF2IRD1-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| MED13L-GTF2IRD1-20-OROR | 20 (40 μL) | 200 μL |
|
|
| MED13L-GTF2IRD1-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| MED13L-GTF2IRD1-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| MED13L-GTF2IRD1-20-GORE | 20 (40 μL) | 200 μL |
|
|
| MED13L-GTF2IRD1-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| MED13L-GTF2IRD1-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| MED13L-GTF2IRD1-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| MED13L-GTF2IRD1-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| MED13L-GTF2IRD1-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| MED13L-GTF2IRD1-20-GROR | 20 (40 μL) | 200 μL |
|
|
| MED13L-GTF2IRD1-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| MED13L-GTF2IRD1-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| MED13L-GTF2IRD1-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| MED13L-GTF2IRD1-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| MED13L-GTF2IRD1-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| MED13L-GTF2IRD1-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| MED13L-GTF2IRD1-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| MED13L-GTF2IRD1-20-AQAQ | 20 (40 μL) | 200 μL |
|
GTF2IRD1 Gene Summary
The protein encoded by this gene contains five GTF2I-like repeats and each repeat possesses a potential helix-loop-helix (HLH) motif. It may have the ability to interact with other HLH-proteins and function as a transcription factor or as a positive transcriptional regulator under the control of Retinoblastoma protein. This gene plays a role in craniofacial and cognitive development and mutations have been associated with Williams-Beuren syndrome, a multisystem developmental disorder caused by deletion of multiple genes at 7q11.23. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2010]
Gene Name: GTF2I Repeat Domain Containing 1
Chromosome: CHR7: 73868119 -74016920
Locus: 7q11.23
MED13L Gene Summary
The protein encoded by this gene is a subunit of the Mediator complex, a large complex of proteins that functions as a transcriptional coactivator for most RNA polymerase II-transcribed genes. The encoded protein is involved in early development of the heart and brain. Defects in this gene are a cause of transposition of the great arteries, dextro-looped (DTGA).[provided by RefSeq, Jul 2010]
Gene Name: Mediator Complex Subunit 13 Like
Chromosome: CHR12: 116396380 -116714991
Locus: 12q24.21
Gene Diseases
The MED13L GTF2IRD1 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Breast Invasive Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|